COVID-19 vaccines and vaccination program for aging adults

Area of Science:

• Gerontology and Immunology
• Vaccinology
• Global Health

Background:

• The aging population faces increased COVID-19 vulnerability and mortality.
• Immunosenescence and inflammaging impact vaccine efficacy in the elderly.
• Existing vaccination programs for influenza, pneumococcal, and herpes zoster inform COVID-19 strategies.

Purpose of the Study:

• To review the current status and future projections of COVID-19 vaccination in the global elderly population.
• To address challenges related to immunosenescence and inflammaging in older adults concerning vaccine effectiveness.
• To propose strategies for global COVID-19 vaccination in the elderly to improve health outcomes and longevity.

Main Methods:

• Comprehensive literature review of global COVID-19 vaccination status in elderly populations.
• Analysis of immunosenescence and inflammaging effects on vaccine response in older adults.
• Projection of future vaccination needs and strategies until 2050.

Main Results:

• Mapping of COVID-19 vaccination coverage in elderly populations across developed and developing countries.
• Identification of specific challenges and needs for elderly vaccination programs.
• Recommendations for clinical trials of approved COVID-19 vaccines in the elderly.

Conclusions:

• Urgent need for targeted clinical trials of COVID-19 vaccines in the elderly population.
• Development of next-generation vaccines tailored for older adults is crucial.
• Global strategies are proposed to ensure comprehensive COVID-19 vaccination for elderly adults, promoting longevity.